Volume: 16

1. 20 Adult-to-Adult Living Donor Liver Transplantations Using Dual Grafts. Page:227—232
2. Trachea Replacement with Cryopreserved Tracheal Allograft: Experiment in Dogs. Page:162—166
3. Experimental Islet Isolation in Porcine Pancreas with New Enzyme Liberase PI. Page:155—161
4. Experience of Consecutive 485 Cases of Living Donor Nephrectomy: Operative Technique and Safety. Page:106—109
5. Effects of Mycophenolic Acid, Rapamycin, and Carvedilol on the PDGF-induced Fibronectin Secretion by Rat Vascular Smooth Muscle Cells: Implication of MAP Kinase. Page:1—8
6. Expression of MIP-1alpha mRNA in Kupffer Cells and Serum MIP-1alpha Post Portal Vein Transfusion. Page:167—171
7. The Results of Renal Transplantation after Lymphocyte Cross-match Negative Conversion by Combination Therapy with Plasmapheresis, Intravenous Gamma Globulin and Potent Immunosuppresants in Patients with Positive LCM. Page:172—177
8. Risk Factors for Chronic Rejection after Renal Transplantation. Page:178—182
9. Kidney Transplantation in Diabetic Patients: Clinical Study in a Single Center. Page:183—188
10. Comparison of C0 and C2 Monitoring in Living-donor Renal Transplantation During Early Post-transplant Period. Page:189—197
11. Validity of C2 Monitoring of Microemulsion Cyclosporine in Early Renal Transplant Period. Page:198—204
12. Pharmacokinetic Study of Mycophenolic Acid in Korean Kidney Transplant Patients. Page:205—214
13. Malignancy in Renal Transplant Recipients. Page:215—218
14. BK Virus Induced Interstitial Nephritis in Renal Transplants: Diagnosis, Treatment and Prognosis. Page:219—226
15. Ultrastructural Changes and Expression of Transforming Growth Factor-beta1 in Tacrolimus- Induced Nephropathy. Page:62—69
16. Mycophenolate Mofetil Versus Azathioprine in Cyclosporine Based Triple Immunosuppression. Page:70—75
17. Clinical Analysis of Efficacy and Safety for FK506 after Renal Transplantation. Page:76—83
18. Comparison of Tacrolimus and Cyclosporine in Kidney Transplantation. Page:84—89
19. Effect of Azithromycin in the Treatment of Cyclosporine-induced Gingival Hyperplasia in Renal Transplant Recipient. Page:90—94
20. Analysis on Risk Factors for Development of Delayed Graft Function in Living Donor Renal Transplantation. Page:95—99
21. Clinical Experiences of 52 Cases Cadaveric Donor Kidney Transplantation. Page:100—105
22. Hematuria in Renal Transplant Patients: Causes and Diagnostic Algorithm. Page:57—61
23. Clinical Implications of Pre-Transplantation Panel Reactive Antibody in Renal Transplantation in Koreans. Page:47—56
24. Association of Polymorphisms of the TNF-alpha and TGF-beta1 Genes with Renal Allograft Dysfunction. Page:38—46
25. Bilateral Lung Transplant Models in Lung Preservation with LPDG Solution. Page:30—37
26. The Regulation of Cytokine and Chemokine Expressions in Skin Xenograft by Aminoguanidine. Page:22—29
27. The Effect of Anti ICAM-1 Antibody in the Rat Kidney Preserved in the Cold University of Wisconsin Solution. Page:16—21
28. The Study on the Mechanism of Cyclosporine A-induced Nephroptoxicity: The Effects of Ceramide and Phospholipase A2 on Cyclosporine A-induced Apoptosis of Renal Tubular Epithelial Cells. Page:9—15
29. Ureteroneocystostomy in Kidney Transplantation with Ureteral Duplication: A Case Report. Page:262—264
30. A Case of Renal Transplantation in a Patient with Goodpasture's Syndrome. Page:258—261
31. Significance of SPECT as a Confirming Test of the Brain Death. Page:251—257
32. Redo Heart Transplantation after Previous Cardiac Operations. Page:246—250
33. Liver Transplantation for Hepatocellular Carcinoma: Single Center Experience for Seventeen Years. Page:244—245
34. Donor Safety in Living Donor Liver Transplantation Using Right Lobe. Page:238—243
35. Stable Hepatocyte Engraftment after Hepatocyte Transplantation Using Biodegradable Injectable Polymer. Page:233—237
36. Two Cases of Combined Transplantation of Liver and Kidney from Two Living Donors. Page:144—148
37. Transplantation of En Bloc Pediatric Cadaver Kidneys into Adult Recipient. Page:141—143
38. A Case of Primary Cutaneous Alternariosis in a Renal Transplant Recipient. Page:137—140
39. A Case of Femoral Neuropathy after Renal Transplantation. Page:133—136
40. Pediatric Liver Transplantation for Metabolic Liver Disease. Page:126—132
41. A Study of the Anti-porcine Endothelial Immunoglobulin and Complement in the Sera of End-stage Renal Failure Patients and End- stage Liver Failure Patients. Page:119—125
42. The Symptom Experience Associated with Immunosuppressive Therapy in Organ Transplant Recipients. Page:110—118